Medicare Enrolled

Dr. Farrukh Awan, M.D., M.S.

Hematology & Oncology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
6201 HARRY HINES BLVD MAIL CODE 8565, Dallas, TX 75390
2146454673
Registered in NPPES since 2007
NPI: 1942424528 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Awan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Awan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Awan

Dr. Farrukh Awan is a hematology & oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Awan performed 658 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Awan received a total of $171,119 from 33 pharmaceutical and/or device companies across 149 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Awan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 658 Medicare services $171,119 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
658
Medicare services
Bottom 37% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
199 $68 $344
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
179 $102 $464
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
130 $94 $336
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $37 $232
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
42 $62 $234
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
24 $90 $341
New patient office visit, complex (60-74 min) 15 $111 $664
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $136 $654
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$171,119
Total received (2018-2024)
Avg $24,446/year across 7 years
Top 4% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
149
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,555
2023
$21,640
2022
$18,392
2021
$8,341
2020
$28,826
2019
$35,746
2018
$47,619

Payments by company (2024)

ABBVIE INC.
$4,492
AstraZeneca Pharmaceuticals LP
$2,930
Invivyd Inc
$2,625
Adaptive Biotechnologies Corporation
$400
Genmab U.S., Inc.
$108
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$46,531
Gilead Sciences, Inc.
$23,330
AbbVie, Inc.
$16,045
Genentech, Inc.
$10,582
Celgene Corporation
$8,046
Genmab U.S., Inc.
$7,273
E.R. Squibb & Sons, L.L.C.
$6,920
BeiGene USA, Inc.
$6,823
ABBVIE INC.
$6,606
Kite Pharma, Inc.
$5,780
Incyte Corporation
$4,922
Lilly USA, LLC
$4,800
AstraZeneca UK Limited
$2,740
Invivyd Inc
$2,625
Verastem, Inc.
$2,024
BeiGene, Ltd.
$1,950
Karyopharm Therapeutics Inc.
$1,938
ADC Therapeutics America, Inc.
$1,750
Genentech USA, Inc.
$1,670
Janssen Scientific Affairs, LLC
$1,515
Merck Sharp & Dohme Corporation
$1,511
Seagen Inc.
$1,475
Epizyme, Inc.,
$1,450
Adaptive Biotechnologies Corporation
$1,034
AbbVie Inc.
$675
GlaxoSmithKline, LLC.
$650
SANOFI-AVENTIS U.S. LLC
$149
GENZYME CORPORATION
$111
Seattle Genetics, Inc.
$95
Sobi, Inc
$47
Kyowa Kirin, Inc.
$24
Rigel Pharmaceuticals, Inc.
$17
Acrotech Biopharma LLC
$12
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BELEODAQ · BRUKINSA · BYDUREON · CALQUENCE · Copiktra · DOPTELET · Epkinly · GAZYVA · IMBRUVICA · JCAR017 · KEYTRUDA · MOZOBIL · PEMGARDA · Poteligeo · Rituxan · TAZVERIK · Tecartus · VENCLEXTA · Venclexta · XPOVIO · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Dallas?
Compare hematology & oncology specialists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
130
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Awan is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Awan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Awan performed 199 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Awan receive payments from pharmaceutical companies?
Yes. Dr. Awan received a total of $171,119 from 33 companies across 149 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Awan's costs compare to other hematology & oncology specialists in Dallas?
Dr. Awan's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Awan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →